The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.

 
Web www.patentalert.com

< Genetically engineered cDNA of rat bcl-x gene and an improved protein

> Biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors

> Endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas

~ 00563